Search research articles
Contact Us
Filters
Showing results (21-30 of 57) with videos related to
Page
of 6
Sort By:
International Journal of Dermatology
|
May 15, 2026
A 52-Week Retrospective Italian Study of Flare Characteristics in Adult Atopic Dermatitis Patients Receiving JAK Inhibitors
Claudio Brescia, Carolina D'Elia, Chiara Palagiano, et al.
International Journal of Dermatology
|
February 8, 2024
Dermoscopic features of dermal duct tumors
Francesca Barei, Alessia Belotti, Paolo Bortoluzzi, et al.
Dermatologic Therapy
|
June 9, 2022
Ulcerative injection site reaction after third COVID-19 vaccine dose with mRNA-1273
Francesca Barei, Dario A Marletta, Ignasi Marti-Marti, et al.
Clinical and Experimental Dermatology
|
August 14, 2024
Successful treatment of prurigo nodularis with upadacitinib
Gianluca Avallone, Andrea Bombelli, Davide Termini, et al.
Journal of Clinical Medicine
|
September 28, 2024
Omalizumab for the Treatment of Chronic Spontaneous Urticaria in Adults and Adolescents: An Eight-Year Real-Life Experience
Paolo Calzari, Alessandra Chiei Gallo, Francesca Barei, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 23, 2024
Assessment of Patient-Reported Outcomes at 48 Months of Treatment with Dupilumab for Severe Atopic Dermatitis: A Single-Center Real-Life Experience with 126 Patients
Francesca Barei, Martina Zussino, Simona Tavecchio, et al.
The Australasian Journal of Dermatology
|
October 21, 2024
Special sites in atopic dermatitis: Effectiveness of dupilumab on the hands in a single-centre study on 485 patients
Gabriele Perego, Italo Francesco Aromolo, Francesca Barei, et al.
Contact Dermatitis
|
January 21, 2025
Severe Allergic Contact Dermatitis to Hair Dye in a Patient With Atopic Dermatitis During Dupilumab Therapy
Alessandra Chiei Gallo, Gianluca Tavoletti, Gianluca Avallone, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 24, 2023
Survival, efficacy and safety of tralokinumab after 32 and 52 weeks of treatment for moderate-to-severe atopic dermatitis in adults: A multicentre real-world study
Elena Pezzolo, Donatella Schena, Alessio Gambardella, et al.
Dermatologic Therapy
|
April 7, 2022
Reply to "New-onset bullous pemphigoid after inactivated Covid-19 vaccine: Synergistic effect of the Covid-19 vaccine and vildagliptin"
Carlo Alberto Maronese, Giovanni Di Zenzo, Giovanni Genovese, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 57) with videos related to
Sort By:
Page
of 6
International Journal of Dermatology
|
May 15, 2026
A 52-Week Retrospective Italian Study of Flare Characteristics in Adult Atopic Dermatitis Patients Receiving JAK Inhibitors
Claudio Brescia, Carolina D'Elia, Chiara Palagiano, et al.
International Journal of Dermatology
|
February 8, 2024
Dermoscopic features of dermal duct tumors
Francesca Barei, Alessia Belotti, Paolo Bortoluzzi, et al.
Dermatologic Therapy
|
June 9, 2022
Ulcerative injection site reaction after third COVID-19 vaccine dose with mRNA-1273
Francesca Barei, Dario A Marletta, Ignasi Marti-Marti, et al.
Clinical and Experimental Dermatology
|
August 14, 2024
Successful treatment of prurigo nodularis with upadacitinib
Gianluca Avallone, Andrea Bombelli, Davide Termini, et al.
Journal of Clinical Medicine
|
September 28, 2024
Omalizumab for the Treatment of Chronic Spontaneous Urticaria in Adults and Adolescents: An Eight-Year Real-Life Experience
Paolo Calzari, Alessandra Chiei Gallo, Francesca Barei, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 23, 2024
Assessment of Patient-Reported Outcomes at 48 Months of Treatment with Dupilumab for Severe Atopic Dermatitis: A Single-Center Real-Life Experience with 126 Patients
Francesca Barei, Martina Zussino, Simona Tavecchio, et al.
The Australasian Journal of Dermatology
|
October 21, 2024
Special sites in atopic dermatitis: Effectiveness of dupilumab on the hands in a single-centre study on 485 patients
Gabriele Perego, Italo Francesco Aromolo, Francesca Barei, et al.
Contact Dermatitis
|
January 21, 2025
Severe Allergic Contact Dermatitis to Hair Dye in a Patient With Atopic Dermatitis During Dupilumab Therapy
Alessandra Chiei Gallo, Gianluca Tavoletti, Gianluca Avallone, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 24, 2023
Survival, efficacy and safety of tralokinumab after 32 and 52 weeks of treatment for moderate-to-severe atopic dermatitis in adults: A multicentre real-world study
Elena Pezzolo, Donatella Schena, Alessio Gambardella, et al.
Dermatologic Therapy
|
April 7, 2022
Reply to "New-onset bullous pemphigoid after inactivated Covid-19 vaccine: Synergistic effect of the Covid-19 vaccine and vildagliptin"
Carlo Alberto Maronese, Giovanni Di Zenzo, Giovanni Genovese, et al.
Page
of 6